Agilent Technologies, Inc. (A)
NYSE: A · Real-Time Price · USD
120.50
-1.47 (-1.21%)
At close: Mar 25, 2025, 4:00 PM
120.51
+0.01 (0.01%)
After-hours: Mar 25, 2025, 4:53 PM EST
Agilent Technologies Employees
Agilent Technologies had 17,900 employees as of October 31, 2024. The number of employees decreased by 200 or -1.10% compared to the previous year.
Employees
17,900
Change (1Y)
-200
Growth (1Y)
-1.10%
Revenue / Employee
$364,972
Profits / Employee
$70,335
Market Cap
34.35B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Oct 31, 2024 | 17,900 | -200 | -1.10% |
Oct 31, 2023 | 18,100 | 0 | - |
Oct 31, 2022 | 18,100 | 1,100 | 6.47% |
Oct 31, 2021 | 17,000 | 600 | 3.66% |
Oct 31, 2020 | 16,400 | 100 | 0.61% |
Oct 31, 2019 | 16,300 | 1,500 | 10.14% |
Oct 31, 2018 | 14,800 | 1,300 | 9.63% |
Oct 31, 2017 | 13,500 | 1,000 | 8.00% |
Oct 31, 2016 | 12,500 | 700 | 5.93% |
Oct 31, 2015 | 11,800 | -9,600 | -44.86% |
Oct 31, 2014 | 21,400 | 800 | 3.88% |
Oct 31, 2013 | 20,600 | 100 | 0.49% |
Oct 31, 2012 | 20,500 | 1,800 | 9.63% |
Oct 31, 2011 | 18,700 | 200 | 1.08% |
Oct 31, 2010 | 18,500 | 1,700 | 10.12% |
Oct 31, 2009 | 16,800 | -2,800 | -14.29% |
Oct 31, 2008 | 19,600 | 200 | 1.03% |
Oct 31, 2007 | 19,400 | 700 | 3.74% |
Oct 31, 2006 | 18,700 | -2,300 | -10.95% |
Oct 31, 2005 | 21,000 | -7,000 | -25.00% |
Oct 31, 2004 | 28,000 | -1,000 | -3.45% |
Oct 31, 2003 | 29,000 | -7,000 | -19.44% |
Oct 31, 2002 | 36,000 | -5,000 | -12.20% |
Oct 31, 2001 | 41,000 | -6,000 | -12.77% |
Oct 31, 2000 | 47,000 | 5,000 | 11.90% |
Oct 31, 1999 | 42,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
A News
- 1 day ago - Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval - Business Wire
- 5 days ago - CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025 - Business Wire
- 5 days ago - Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025 - Business Wire
- 6 days ago - Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski - Business Wire
- 15 days ago - Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications - Business Wire
- 21 days ago - Agilent Technologies, Inc. (A) TD Cowen 45th Annual Healthcare Conference (Transcript) - Seeking Alpha
- 24 days ago - Agilent Technologies: Recent Price Weakness Makes This Stock A Buy - Seeking Alpha
- 25 days ago - Agilent to Participate in TD Cowen Health Care Conference - Business Wire